Renal targeting of a non-steroidal anti-inflammatory drug: Effects on renal prostaglandin synthesis in the rat

Clinical Science

Volumn 95, Issue 5, 1998, Pages 603-609

  Haas, Marijke ^a,b   Moolenaar, Frits ^b   Meijer, Dirk K F ^b   De Jong, Paul E ^a   De Zeeuw, Dick ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Drug targeting; Kidney; Low molecular mass protein; Lysozyme; Naproxen; Non steroidal anti inflammatory drug; Prostaglandins

Indexed keywords

DRUG METABOLITE; FUROSEMIDE; LYSOZYME; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIURESIS; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG TARGETING; FLUID INTAKE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; RAT; SODIUM EXCRETION; URINARY EXCRETION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DINOPROSTONE; DIURETICS; DRUG CARRIERS; FUROSEMIDE; KIDNEY; MALE; MURAMIDASE; NAPROXEN; NATRIURESIS; RATS; RATS, WISTAR; URINATION;

EID: 0031738703     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0950603     Document Type: Article

References (39)

1. Haas, M., Meijer, D. K. F., Moolenaar, F., de Jong, P. E. and de Zeeuw, D. (1996) Renal drug targeting: optimalisation of renal pharmacotherapeutics. In International Yearbook of Nephrology (Andreucci, V. E. and Fine, L. G., eds.), pp. 3-11, Oxford University Press, Oxford
2. Franssen, E. J. F., Moolenaar, F., de Zeeuw, D. and Meijer, D. K. F. (1994) Drug targeting to the kidney with low-molecular-weight proteins. Adv. Drug Delivery Rev. 14, 67-88
3. Maack, T., Johnson, V., Kau, S. T., Figueiredo, J. and Sigulem, D. (1979) Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Im. 16, 251-270
4. Maack, T., Park, C. H. and Camargo, M. J. F. (1985) Renal filtration, transport, and metabolism of proteins. In The Kidney, Physiology and Pathophysiology (Seldin, D. W. and Giebisch, G., eds.), Raven Press, New York, pp. 1773-1803
5. Christensen, E. I. and Nielsen, S. (1991) Structural and functional features of protein handling in the kidney proximal tubule. Semin. Nephrol. 11, 414-439
6. Franssen, E. J. F., van Amsterdam, R. G. M., Visser, J., Moolenaar, F., de Zeeuw, D. and Meijer, D. K. F. (1991) Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme. Pharm. Res. 8, 1223-1230
7. Haas, M., Kluppel, C. A., Wartna, E. S. et al. (1997) Drug targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in-vivo. Kidney Int. 52, 1693-1699
8. Favre, L., Glasson, P., Riondel, A. and Vallotton, M. B. (1983) Interaction of diuretics and non-steroidal anti-inflammatory drugs in man. Clin. Sci. 64, 407-415
9. Izumi, Y., Franco-Saenz, S. R. and Mulrow, P. J. (1985) Effects of prostaglandin synthesis inhibitors on the renin-angiotensin system and renal function. Hypertension 7, 791-796
10. Martin, U. and Prescott, L. F. (1994) The interaction of paracetamol with frusemide. Br. J. Clin. Pharmacol. 37, 464-467
11. Kirchner, K. A., Brandon, S., Mueller, R. A., Smith, M. J. and Bower, J. D. (1987) Mechanism of attenuated hydrochlorothiazide response during indomethacin administration. Kidney Int. 31, 1097-1103
12. Oliw, E., Kövér, G., Larsson, C. and Änggård, E. (1976) Reduction by indomethacin of furosemide effects in the rabbit. Eur. J. Pharmacol. 38, 95-100
13. Chan, W. Y. (1988) Renal prostaglandins and natriuretic action of oxytocin and vasopressin in rats. J. Pharmacol. Exp. Ther. 246, 603-609
14. 2. Am. J. Physiol. 247, F555-F561
15. Patrono, C. and Dunn, M. J. (1987) The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int. 32, 1-12
16. Dunn, M. J. and Zambraski, E. J. (1980) Renal effects of drugs that inhibit prostaglandin synthesis. Kidney Int. 18, 609-622
17. Davila, D., Davila, T., Oliw, E. and Änggård, E. (1978) The influence of dietary sodium on urinary prostaglandin excretion. Acta Physiol. Scand. 103, 100-106
18. 2 biosynthesis by dietary restriction of sodium. Am. J. Physiol. 6, F344-F349
19. Brater, D. C. (1985) Resistance to loop diuretics. Why it happens and what to do about it. Drugs 30, 427-443
20. Kirchner, K. A. (1987) Indomethacin antagonizes furosemide's intratubular effects during loop segment microperfusion. J. Pharmacol. Exp. Ther. 243, 881-886
21. Kirchner, K. A. (1988) Role of antidiuretic hormone in the attenuated furosemide response observed during indomethacin administration. J. Lab. Clin. Med. 111, 237-243
22. 2 excretion following furosemide in rats. Life Sci. 55, 707-711
23. Anderson, G. W., Zimmerman, J. E. and Callahan, F. M. (1964) The use of esters of N-hydroxysuccinimide in peptide synthesis. J. Am. Chem. Soc. 89, 1839-1842
24. Steffens, A. B. (1964) A method for frequent sampling of blood and continuous infusion of fluids without disturbing the animal. Physiol. Behav. 4, 833-836
25. 2 binding characteristics in rat kidney. Acta Physiol. Scand 138, 451-461
26. Oliw, E., Lunden, I. and Ånggård, E. (1978) In vivo inhibition of prostaglandin synthesis in rabbit kidney by non-steroidal anti-inflammatory drugs. Acta Pharmacol. Toxicol. 42, 179-184
27. Brater, D. C., Anderson, S., Baird, B. and Campbell, W. B. (1985) Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. Kidney Int. 27, 66-73
28. Runkel, R., Chaplin, M., Boost, G., Segre, E. and Forchielli, E. (1972) Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. J. Pharm. Sci. 61, 703-708
29. Kirchner, K. A. (1985) Prostaglandin inhibitors alter loop segment chloride uptake during furosemide diuresis. Am. J. Physiol. 248, F698-F704
30. Wilson, D. R., Honrath, U. and Sonnenberg, H. (1983) Furosemide action on collecting ducts: effect of prostaglandin synthesis inhibition. Am. J. Physiol. 244, F666-F673
31. Schlondorff, D. (1986) Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins. Am. J. Med. 81, 1-11
32. Cox, P. G. F., Moons, W. M., Russel, F. G. and van Ginneken, C. A. M. (1990) Renal disposition and effects of naproxen and its L-enantiomer in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 255, 491-496
33. Zoja, C., Benigni, A., Verroust, P., Ronco, P., Bertani, T. and Remuzzi, G. (1987) Indomethacin reduces proteinuria in passive Heymann nephritis in rats. Kidney Int. 31, 1335-1343
34. Benigni, A., Zoja, C., Remuzzi, A., Orisio, S., Piccinelli, A. and Remuzzi, G. (1986) Role of renal prostaglandins in normal and nephrotic rats with diet-induced hyperfiltration. J. Lab. Clin. Med. 108, 230-240
35. Bertani, T., Benigni, A., Cutillo, F. et al. (1986) Effect of aspirin and sulindac in rabbit nephrotoxic nephritis. J. Lab. Clin. Med. 107, 261-268
36. Neugarten, J., Kozin, A. and Cook, K. (1989) Effect of indomethacin on glomerular permselectivity and hemodynamics in nephrotoxic serum nephritis. Kidney Int. 36, 51-56
37. Vriesendorp, R., de Zeeuw, D., de Jong, P. E., Donker, A. J., Pratt, J. J. and van der Hem, G. K. (1986) Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs. Clin. Nephrol. 25, 105-110
38. Vriesendorp, R., Donker, A. J., de Zeeuw, D., de Jong, P. E., van der Hem, G. K. and Brentjens, J. R. (1986) Effects of nonsteroidal anti-inflammatory drugs on proteinuria. Am. J. Med. 81, 84-94
39. Usberti, M., Pecoraro, C., Federico, S. et al. (1985) Mechanism of action of indomethacin in tubular defects. Pediatrics 75, 501-507